Skip to content

A comparison between the two methods of artificial graft placement in the superficial and the common femoral arteries.

A comparison study o fthe PTFE graft patency rate and the complicationsin in the superficial and the common femoral arteries in the dyalysis patents.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013021812514N1
Enrollment
40
Registered
2013-05-12
Start date
2011-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: In the intervention group, the synthetic graft for access to dialysis is placed between the superficial femoral artery and vein. Intervention 2: In the control group using the conventi
Treatment - Surgery
In the intervention group, the synthetic graft for access to dialysis is placed between the superficial femoral artery and vein.
In the control group using the conventional method, the synthetic graft for access to dialysis is placed between the common femoral artery and vein.

Sponsors

Vice chancellor for research, Kermanshah University of Medical Sciences, Shid Behshti blvd, Kermans
Lead Sponsor

Eligibility

Sex/Gender
All
Age
28 Years to 86 Years

Inclusion criteria

Inclusion criteria: The main criteria for inclusion: Patients in whom it is not possible more arteriovenous fistulas be accomplished The main criteria for exclusion: Patients with malignancy and coagulopathy are excluded

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Comparison of graft patency rate. Timepoint: Every three months. Method of measurement: Surgeon diagnosis.

Secondary

MeasureTime frame
Pseudoaneurysm. Timepoint: Every three months. Method of measurement: Surgeon diagnosis.;Graft thrombosis. Timepoint: Every three months. Method of measurement: Surgeon diagnosis.;Infection. Timepoint: Every three months. Method of measurement: Surgeon diagnosis.;Hematoma Hematom. Timepoint: Every three months. Method of measurement: Surgeon diagnosis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahramabadi Hojat

Kermanshah University of Medical Sciences

Dr.B.Bahramabadi@kums.ac.ir+98 831883142763

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026